MedPath

Comparison of Insulin degludec vs. Insulin glargine using continuous glucose monitoring (CGM): Crossover study

Not Applicable
Conditions
Type 2 diabetes mellitus
Registration Number
JPRN-UMIN000010847
Lead Sponsor
Ichinomiyanishi Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
16
Inclusion Criteria

Not provided

Exclusion Criteria

1) severe renal dysfunction (serum creatinine level ≥2 mg/dL) 2) judged to be unsuitable for participation for medical reasons.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath